Dr. Philip M. Arlen gives Immunotherapy Section Opening Keynote at Festival of Biologics, San Diego, March 9, 2022
Dr. Philip M. Arlen gives Immunotherapy Section Opening Keynote at Festival of Biologics 2022, San...
Dr. Philip M. Arlen gives Immunotherapy Section Opening Keynote at Festival of Biologics 2022, San...
Dr. Joyson Karakunnel joins the Board of Directors of Precision Biologics, Inc. as its newest...
Dr. Philip M. Arlen gives scientific presentation at Biomarkers UK: In-Person, Day 1 – November...
The Phase 2 Clinical Trial with a safety lead in, combining Precision Biologics monoclonal antibody...
Dr Massimo Fantini, Director of Research is Presenting the following Talk entitled : “Stability Tests...
Precision Biologics announces that a Phase 2 Clinical Trial, combining NEO-201 with Pembrolizumab, is recruiting...
Dr. Philip M. Arlen gives scientific presentation at the 4th Annual Europe Neoantigen summit, Clinical...
Dr. Philip M. Arlen gives scientific presentation at the Festival of Biologics, World Immunotherapy Congress,...
Dr. Philip M. Arlen gives scientific presentation at World Vaccine & Immunotherapy Congress West Coast...
Dr. Philip M. Arlen gives scientific presentation in 5th Annual Neoantigen Based Therapies Summit, entitled...